Hepatitis C virus infection in patients with oral lichen planus

Niger J Clin Pract. 2011 Apr-Jun;14(2):228-31. doi: 10.4103/1119-3077.84025.

Abstract

Background: Lichen planus (LP) is a chronic mucocutaneous disease of uncertain etiology. Recent reports suggest that LP is an extrahepatic manifestation of Hepatitis C infection.

Objective: To determine the association of Hepatitis C virus (HCV) infection with oral LP and to study the tests of liver function in patients with oral LP.

Study design: A cross-sectional case-control study was carried out on 25 patients with oral LP and an equal number of controls. The study was conducted in the outpatient department of a dental college for a period of six months between January and June 2008. The sera of the patients and controls were tested for HCV ribonucleic acid (RNA) using reverse transcription primed-polymerase chain reaction and liver function tests (bilirubin, transaminases, and alkaline phosphatase).

Results: Of the 25 patients with LP, three (12%) had HCV infection. None of the controls had HCV RNA positivity ( P = 0.2347). Oral LP patients had higher serum bilirubin and transaminases when compared with controls ( P < 0.05). However, there was no significant difference in alkaline phosphatase. HCV-positive and -negative patients did not differ significantly in liver function tests.

Conclusions: An increased prevalence of HCV infection was seen in oral LP patients. Our findings support a possible etiological association between these two diseases.

MeSH terms

  • Adult
  • Aged
  • Case-Control Studies
  • Cross-Sectional Studies
  • Female
  • Hepacivirus* / genetics
  • Hepacivirus* / isolation & purification
  • Hepatitis C / complications*
  • Hepatitis C / diagnosis
  • Hepatitis C / epidemiology
  • Hepatitis C Antibodies / blood
  • Hepatitis C Antibodies / genetics
  • Humans
  • Lichen Planus, Oral / complications*
  • Lichen Planus, Oral / etiology
  • Lichen Planus, Oral / virology
  • Liver Function Tests
  • Male
  • Middle Aged
  • Nigeria / epidemiology
  • Prevalence
  • RNA, Viral / blood*
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Hepatitis C Antibodies
  • RNA, Viral